Drug Profile
Diclofenac topical - Avecho Biotechnology
Alternative Names: TPM®/diclofenac gel; TPM®/diclofenac transdermal matrix patch; Voveran TPMLatest Information Update: 23 Feb 2023
Price :
$50
*
At a glance
- Originator Phosphagenics
- Developer Avecho Biotechnology; Nippon Zoki; Novartis; Themis Medicare
- Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Musculoskeletal pain
- No development reported Pain
Most Recent Events
- 23 Feb 2023 Launched for Musculoskeletal pain in European Union (Topical) before February 2023 (Avecho Biotechnology pipeline, February 2023)
- 23 Feb 2023 Launched for Musculoskeletal pain in USA (Topical) before February 2023 (Avecho Biotechnology pipeline, February 2023)
- 28 Apr 2018 No recent reports of development identified for preclinical development in Pain in USA (Topical, Patch)